Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01425944 · ClinicalTrials.gov registry record
Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
A clinical trial of Sturge-Weber Syndrome, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Active
- Registry status
- 600
- Enrollment target
- 7
- Study locations
NCT01425944: Active study of Sturge-Weber Syndrome, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
NCT01425944 is a study of Sturge-Weber Syndrome that is active but no longer recruiting, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 600 participants. The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01425944, a study of Sturge-Weber Syndrome, is active but no longer recruiting, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study has three aims that hope to expand the knowledge on the cause of Sturge-Weber Syndrome (SWS) and improve clinical care of Sturge-Weber Syndrome patients.
Primary Outcome
Descriptive statistics for the national database, correlation between neurologic score and urine angiogenesis factor, and correlation between PWS (port-wine stain) attributes, urine vascular factors, and neuroscore
Conditions Studied
Study Locations (7)
Ohio
- Cincinnati Children's Hospital - Cincinnati
- Nationwide Children's Hospital - Columbus
Maryland
- Kennedy Krieger Institute - Baltimore
Michigan
- Wayne State University/Children's Hospital of Michigan - Detroit
New York
- New York University - New York
Pennsylvania
- Wills Eye Institute - Philadelphia
Texas
- Baylor College of Medicine/Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2010-09 |
| Est. Completion | 2027-02-09 |
What the registry record for NCT01425944 still lists
NCT01425944 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Sturge-Weber Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT01425944 lists 7 locations in 6 states (Ohio, Maryland, Michigan).
Frequently Asked Questions
What is clinical trial NCT01425944 about?
NCT01425944 is a clinical study titled "Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome". This study has three aims that hope to expand the knowledge on the cause of Sturge-Weber Syndrome (SWS) and improve clinical care of Sturge-Weber Syndrome patients.
What is the current status of trial NCT01425944?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2010-09. Estimated completion is 2027-02-09.
What conditions does trial NCT01425944 study?
This clinical trial studies the following conditions: Sturge-Weber Syndrome.
Who is sponsoring clinical trial NCT01425944?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01425944 being conducted?
This trial has 7 study locations across Maryland, Michigan, New York, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sturge-Weber Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia